Elon Musk’s Neuralink says it has FDA approval for human testing for brain implants

Neuralink, the California-based neurotechnology company owned by Elon Musk, said Friday it has approval from the U.S. Food and Drug Administration of a human clinical trial for its brain implant.

Share on FacebookEmail this to someoneShare on Google+Tweet about this on TwitterPrint this pageShare on LinkedInShare on StumbleUponShare on TumblrShare on RedditFlattr the authorPin on PinterestBuffer this pageDigg this